Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrivalent LAIV immunogenicity study in children
2009-013326-17Phase 3
- Sponsor
- MedImmune
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing MEDI3250 with MEDI-558 active control (2 arms). Primary endpoint: Post-dose strain-specific serum hemagglutination inhibition antibody geometric mean titers.
02
Drugs
live attenuated influenza vaccineinfluenza vaccine (live attenuated)
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-013326-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013326-17.